Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2- c ]pyridine Mannich bases
作者:Gilish Jose、Tholappanavara H. Suresha Kumara、Haliwana B.V. Sowmya、Dharmarajan Sriram、Tayur N. Guru Row、Amar A. Hosamani、Sunil S. More、Bhavya Janardhan、B.G. Harish、Sandeep Telkar、Yalegara Siddappa Ravikumar
DOI:10.1016/j.ejmech.2017.03.015
日期:2017.5
using MABA. Compounds 7r, 7t, and 7u were showed good antitubercular activity against Mtb (MIC ≥6.25 μg/mL). Among the tested compounds, 1-((4-chloro-2-(cyclohexylmethyl)-1H-pyrrolo[3,2-c]pyridin-3-yl)methyl)piperidine-3-carboxamide (7t) was showed excellent antimycobacterial activity against Mtb (MIC <0.78 μg/mL) and low cytotoxicity against the HEK-293T cell line (SI >>25). Molecular docking of the
在本报告中,我们描述了一系列新的吡咯并[3,2-c]吡啶曼尼希碱(7a-v)的合成和生物学评估。曼尼希碱是通过吡咯并[3,2-c]吡啶骨架(6a-c)与仲胺和过量的甲醛溶液在AcOH中一锅三组分缩合获得的。化合物的化学结构通过1 H NMR,13 C NMR,LC / MS和元素分析进行表征。已记录化合物7k([C23H29ClN4] +2,H2O)的单晶X射线衍射。使用琼脂扩散法和肉汤微量稀释法评估了化合物对各种细菌和真菌菌株的体外抗菌活性。化合物7e,7f,7r,7t和7u对金黄色葡萄球菌,弯曲弯曲杆菌,产气链球菌和变形链球菌显示出良好的革兰氏阳性抗菌活性。此外,使用MABA评估了对结核分枝杆菌H37Rv(ATCC 27294)的体外抗分枝杆菌活性。化合物7r,7t和7u对Mtb(MIC≥6.25μg/ mL)表现出良好的抗结核活性。在测试的化合物中,1-((4-氯-2-(环己基甲基)-1H-吡咯并[3